Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:27:32.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The publications note at the bottom was updated to indicate PubMed-listed publications are automatically filled from PubMed and may not be about the study, and the revision version changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:27:33.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Removal of a site-wide banner about government funding and operating status from the page. This does not affect the study details or the core information presented about the Nivo40 trial.
    Difference
    0.4%
    Check dated 2025-11-18T06:51:07.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The screenshots show only UI/layout updates with no changes to the study's core details (eligibility criteria, endpoints, or results). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:46:07.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page now includes a funding-related operating status notice and a new version badge (v3.2.0), replacing the previous v3.1.0. This signals updated operational status and a software release, altering expectations for data processing and reliability.
    Difference
    5%
    Check dated 2025-10-06T04:59:31.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:57:25.000Z thumbnail image

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.